Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

48.26 USD +0.50 (+1.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 417,571
Open 48.24
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 47.76
Today's Range 48.07 - 48.32
52wk Range 39.72 - 48.78
Shares Outstanding N/A
Dividend Yield 1.90%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA),... 
From Business Wire News Releases
Data for Genentech’s Evrysdi (risdiplam) Published in New England Journal of Medicine Shows Significant Improvement in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the New England Journal of Medicine (NEJM) has published data from FIREFISH Part 2, a pivotal global study... 
From Business Wire News Releases

Performance

YTD
+9.98%
+9.98%
1 Month
+1.64%
+1.64%
3 Month
+16.71%
+16.71%
6 Month
+10.94%
+10.94%
1 Year
+9.28%
+9.28%

More News

Read More
Spark Therapeutics’ SPK-8011 Suggests Stable and Durable Factor VIII Expression in Largest Phase 1/2 Gene Therapy Study in Hemophilia A to Date
From GlobeNewswire News Releases
Roche's Faricimab US Application For Ocular Diseases Under Priority Review
Tags RHHVF Wet AMD RHHBY
From Benzinga
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Tags RHHBY ABBV Market News
From Motley Fool
INFI Stock: Why Infinity Pharmaceuticals Is Soaring After Tuesday’s Plunge
Tags Today's Market RHHBY Market News
From InvestorPlace
OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
Tags CYDY Penny Stocks Emerging Markets
From Benzinga
Infinity Pharma Stock Drops After Updated Data From Bladder & Breast Cancer Trials, Q2 Earnings
Tags breast cancer Guidance RHHVF
From Benzinga
FDA Grants Breakthrough Therapy Designation for Venclexta in Combination With Azacitidine for the Treatment of Patients With Myelodysplastic Syndromes
From Business Wire News Releases
Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters
Tags Briefs RHHBY News
From Benzinga
Rebound In COVID-19 Tests Lift Roche's Half-Year Sales, Oncology Still Hit By Biosimilars, Pandemic
Tags General Dividends RHHBF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.